サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1468201

抗感染症薬市場レポート：タイプ別、投与経路別、流通チャネル別、地域別、2024年～2032年

Anti-infectives Market Report by Type, Route of Administration (Topical, Oral, Intravenous, and Others), Distribution Channel, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 137 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
抗感染症薬市場レポート：タイプ別、投与経路別、流通チャネル別、地域別、2024年～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗感染症薬市場規模は2023年に1,347億米ドルに達しました。今後、IMARC Groupは、市場が2032年までに1,775億米ドルに達し、2024～2032年の成長率（CAGR）は3.05%になると予測しています。

抗感染症薬とは、感染症の拡大を抑制したり、感染因子を完全に死滅させたりすることで、感染症に作用する医薬品です。これらの医薬品には、抗生物質、抗ウイルス薬、抗真菌薬、抗マラリア薬、駆虫薬、抗原虫薬などが含まれます。これらの薬は一般的に経口、非経口、局所投与されます。肺炎や結核を含む軽度の感染症の治療に広く使用されています。これとは別に、抗感染症薬は、帝王切開や人工関節置換術など、重症感染症のリスクが高い日常的な処置や手術の際にも利用されています。

抗感染症薬市場の動向：

世界の抗感染症薬市場は、主に世界中で感染症が増加していることが要因となっています。抗感染症薬は、ウイルス、細菌、寄生虫、真菌などの感染症の治療に使用されます。さらに、天然物、クオラムセンシング阻害剤、バイオフィルム破壊剤、ガリウムベースの薬剤、シクロデキストリン阻害剤、光ベースの抗菌剤など、さまざまな戦略を用いて製剤化された新規薬剤の開拓が、市場成長に弾みをつけています。これに伴い、幹細胞や臓器オンチップ（OOC）技術など、創薬手順における最新の技術革新が創薬試験プロセスを強化し、市場に明るい展望をもたらしています。さらに、アスペルギルス症、侵襲性カンジダ症、粘菌症などのCOVID-19疾患や誘発感染症の出現による製品採用の増加が、市場の成長を強化しています。これに加えて、規制当局によって承認される新しい抗感染症薬の数が増加していることも、成長を促進する要因として作用しています。さらに、有利な政府政策の実施、革新的な新薬開発への投資の増加、感染症に対する個人の意識の高まり、急速に改善するヘルスケアインフラは、今後数年間の市場成長を促進すると予想されます。

本レポートで扱う主な質問

  • 2023年の世界の抗感染症薬市場規模は？
  • 2024～2032年の世界の抗感染症薬市場の予想成長率は？
  • 世界の抗感染症薬市場を牽引する主要因は何か？
  • COVID-19が世界の抗感染症薬市場に与えた影響は？
  • 世界の抗感染症薬市場のタイプ別区分は？
  • 投与経路に基づく抗感染症薬の世界市場内訳は？
  • 世界の抗感染症薬市場の流通経路別区分は？
  • 抗感染症薬の世界市場における主要地域は？
  • 抗感染症薬の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の抗感染症薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 抗菌剤
    • 市場動向
    • 市場予測
  • 抗真菌
    • 市場動向
    • 市場予測
  • 抗ウイルス剤
    • 市場動向
    • 市場予測

第7章 市場内訳：投与経路別

  • 外用剤
    • 市場動向
    • 市場予測
  • 経口剤
    • 市場動向
    • 市場予測
  • 静脈注射剤
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • 専門薬局
    • 市場動向
    • 市場予測
  • オンラインストア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Cipla Health Ltd.（Cipla Limited）
    • F. Hoffmann-La Roche AG
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals Limited
    • Johnson & Johnson
    • Lupin Limited
    • Sandoz AG（Novartis AG）
    • Sun Pharmaceutical Industries Limited
図表

List of Figures

  • Figure 1: Global: Anti-infectives Market: Major Drivers and Challenges
  • Figure 2: Global: Anti-infectives Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Anti-infectives Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Anti-infectives Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Anti-infectives Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Anti-infectives Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Anti-infectives Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Anti-infectives (Antibacterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Anti-infectives (Antibacterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Anti-infectives (Antifungal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Anti-infectives (Antifungal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Anti-infectives (Antiviral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Anti-infectives (Antiviral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Anti-infectives (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Anti-infectives (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Anti-infectives (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Anti-infectives (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Anti-infectives (Intravenous (IV)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Anti-infectives (Intravenous (IV)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Anti-infectives (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Anti-infectives (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Anti-infectives (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Anti-infectives (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Anti-infectives (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Anti-infectives (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Anti-infectives (Speciality Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Anti-infectives (Speciality Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Anti-infectives (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Anti-infectives (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Anti-infectives (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Anti-infectives (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Anti-infectives Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Anti-infectives Industry: SWOT Analysis
  • Figure 82: Global: Anti-infectives Industry: Value Chain Analysis
  • Figure 83: Global: Anti-infectives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Anti-infectives Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Anti-infectives Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Anti-infectives Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Anti-infectives Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Anti-infectives Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Anti-infectives Market: Competitive Structure
  • Table 7: Global: Anti-infectives Market: Key Players
目次
Product Code: SR112024A6073

The global anti-infectives market size reached US$ 134.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 177.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.05% during 2024-2032.

Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.

Anti-infectives Market Trends:

The global anti-infectives market is primarily driven by rising incidences of infectious diseases across the globe. Anti-Infinitives are used to treat infections, including viruses, bacteria, parasites, and fungi. Additionally, the development of novel drugs that are formulated using different strategies, such as natural products, quorum sensing inhibitors, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors, and light-based antimicrobials, are providing an impetus to the market growth. In line with this, the latest innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are creating a positive outlook for the market. Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-infectives market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, route of administration and distribution channel.

Breakup by Type:

Antibacterial

Antifungal

Antiviral

Breakup by Route of Administration:

Topical

Oral

Intravenous (IV)

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Speciality Pharmacies

Online Stores

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.

Key Questions Answered in This Report

  • 1. What was the size of the global anti-infectives market in 2023?
  • 2. What is the expected growth rate of the global anti-infectives market during 2024-2032?
  • 3. What are the key factors driving the global anti-infectives market?
  • 4. What has been the impact of COVID-19 on the global anti-infectives market?
  • 5. What is the breakup of the global anti-infectives market based on the type?
  • 6. What is the breakup of the global anti-infectives market based on the route of administration?
  • 7. What is the breakup of the global anti-infectives market based on distribution channel?
  • 8. What are the key regions in the global anti-infectives market?
  • 9. Who are the key players/companies in the global anti-infectives market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Anti-infectives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Antibacterial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Antifungal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Antiviral
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Topical
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Intravenous (IV)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Speciality Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Cipla Health Ltd. (Cipla Limited)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 F. Hoffmann-La Roche AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 GlaxoSmithKline plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Glenmark Pharmaceuticals Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Lupin Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sandoz AG (Novartis AG)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Sun Pharmaceutical Industries Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis